This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Emerging Biotech Companies Discuss What’s In The Pipeline At NYSSA Conference

Insiders from some of the sector’s most innovative small- and micro-cap biotech companies will discuss their progress with trials and their plans to develop, research, and market important new drugs, diagnostics and delivery technologies at the New York Society of Security Analysts’ 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011.

The agenda also includes an outlook on the industry from Yigal D. Nochomovitz, PhD, senior biotechnology analyst and senior vice president at Rodman & Renshaw, LLC.

A 2011 study indicated that the majority of investors expect that biotech will outperform the overall healthcare sector in 2011 and 2012, with just over one-third forecasting double-digit returns. NYSSA has brought together executives from these emerging biotech companies who will give 35-minute presentations on their company’s prospects to members of the Wall Street community:

  • Cardio3BiosciencesChristian Homsy, CEO
  • DARA BioSciences, Inc. (Nasdaq: DARA)Richard A. Franco, President, CEO and Chairman
  • EpiCept Corporation (Nasdaq: EPTC)Jack Talley, President and CEO
  • Galena Biopharma (Nasdaq: RXII)Mark Schwartz, PhD, EVP and COO
  • NanoViricides, Inc.Eugene Seymour, MD, MPH, CEO
  • OncoSec Medical Inc.Punit Dhillon, President and CEO
  • Provectus Pharmaceuticals, Inc. (OTC: PVCT)Craig Dees, PhD, CEO
  • Senesco Technologies (AMEX: SNT)Leslie J. Browne, President and CEO
  • TONIX Pharmaceuticals (OTCBB: TNXP)Dr. Seth Lederman, President and Chairman

The full-day conference will be held on November 30, 2011 from 8:30 a.m.–4:10 p.m. at NYSSA Conference Center, 1540 Broadway, Suite 1010, New York, NY 10036.

For more information on the conference, please visit: www.nyssa.org/biotech.

There is no charge for press with credentials.

About NYSSA

The New York Society of Security Analysts (NYSSA) is a leading forum for the investment community. NYSSA’s mission is to promote best practices and the highest professional and ethical standards in the industry. With 10,000 members, NYSSA is the largest of the 135 societies worldwide that make up CFA Institute, which has over 105,000 members. For more information about NYSSA, please visit http://www.nyssa.org. Follow NYSSA on Facebook, Twitter and Finance Professionals’ Post.

Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs